UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Archives of toxicology, 2020-04, Vol.94 (4), p.1367-1369

2020

Volltextzugriff (PDF)

Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

Cells (Basel, Switzerland), 2019-12, Vol.9 (1), p.37

2019

Volltextzugriff (PDF)

Macrophages clear out necrotic liver lesions: a new magic trick revealed

eGastroenterology, 2023-12, Vol.1 (2), p.e100024

2023

Volltextzugriff (PDF)

Infections at the nexus of metabolic-associated fatty liver disease

Archives of toxicology, 2021-07, Vol.95 (7), p.2235-2253

2021

Volltextzugriff (PDF)

Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH

Pharmacological research, 2019-06, Vol.144, p.377-389

2019

Volltextzugriff (PDF)

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Cell biology and toxicology, 2021-04, Vol.37 (2), p.293-311

2021

Volltextzugriff (PDF)

Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index

PloS one, 2018-09, Vol.13 (9), p.e0203846-e0203846

2018

Volltextzugriff (PDF)

Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses

Viruses, 2022-10, Vol.14 (10), p.2292

2022

Volltextzugriff (PDF)

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

Cells (Basel, Switzerland), 2022-03, Vol.11 (5), p.893

2022

Volltextzugriff (PDF)

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights

Biomedicines, 2022-01, Vol.10 (1), p.161

2022

Volltextzugriff (PDF)

Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH

MethodsX, 2020-01, Vol.7, p.101068-101068, Article 101068

2020

Volltextzugriff (PDF)

Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells

Cells (Basel, Switzerland), 2020-04, Vol.9 (4), p.914

2020

Volltextzugriff (PDF)

Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor

Data in brief, 2019-08, Vol.25, p.104093, Article 104093

2019

Volltextzugriff (PDF)

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Pharmacology & therapeutics (Oxford), 2023-03, Vol.243, p.108353-108353, Article 108353

2023

Volltextzugriff (PDF)

Liver stiffness as a cornerstone in heart disease risk assessment

Liver international, 2024-02, Vol.44 (2), p.344-356

2024

Volltextzugriff (PDF)

Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank

Liver international, 2023-06, Vol.43 (6), p.1360-1361

2023

Volltextzugriff (PDF)

WED-428 - In vitro investigation of the role of adipocyte-derived exosomes in the development of non-alcoholic steatohepatitis

Journal of hepatology, 2023-06, Vol.78, p.S752-S752

2023

Volltextzugriff (PDF)

Human skin stem cell-derived hepatic cells with genetic predisposition for liver fat accumulation mimic susceptibility to develop metabolic dysfunction-associated fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S775-S776

2023

Volltextzugriff (PDF)

In vitro investigation of the role of adipocyte-derived exosomes in the development of non-alcoholic steatohepatitis

Journal of hepatology, 2023-06, Vol.78, p.S752

2023

Volltextzugriff (PDF)

WED-465 - Human skin stem cell-derived hepatic cells with genetic predisposition for liver fat accumulation mimic susceptibility to develop metabolic dysfunction-associated fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S775-S776

2023

Volltextzugriff (PDF)

Human-based systems: Mechanistic NASH modelling just around the corner?

Pharmacological research, 2018-08, Vol.134, p.257-267

2018

Volltextzugriff (PDF)

Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code

Journal of hepatology, 2021-09, Vol.75 (3), p.690-705

2021

Volltextzugriff (PDF)

Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19

Diagnostic microbiology and infectious disease, 2021-06, Vol.100 (2), p.115350-115350, Article 115350

2021

Volltextzugriff (PDF)

An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices

Journal of Chromatography A, 2021-01, Vol.1637, p.461807, Article 461807

2021

Volltextzugriff (PDF)

PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review

Liver international, 2023-05, Vol.43 (5), p.975-988

2023

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

Macrophages clear out necrotic liver lesions: a new magic trick revealed

Infections at the nexus of metabolic-associated fatty liver disease

Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index

Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights

Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH

Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells

Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Liver stiffness as a cornerstone in heart disease risk assessment

Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank

WED-428 - In vitro investigation of the role of adipocyte-derived exosomes in the development of non-alcoholic steatohepatitis

Human skin stem cell-derived hepatic cells with genetic predisposition for liver fat accumulation mimic susceptibility to develop metabolic dysfunction-associated fatty liver disease

In vitro investigation of the role of adipocyte-derived exosomes in the development of non-alcoholic steatohepatitis

WED-465 - Human skin stem cell-derived hepatic cells with genetic predisposition for liver fat accumulation mimic susceptibility to develop metabolic dysfunction-associated fatty liver disease

Human-based systems: Mechanistic NASH modelling just around the corner?

Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code

Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19

An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices

PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review

Suchergebnisse filtern